SODIUM PHOSPHATES INJECTION USP
SANDOZ CANADA INCORPORATED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of SODIUM PHOSPHATES INJECTION USP in Canada?
Yes. SODIUM PHOSPHATES INJECTION USP 268MG 276MG has an active shortage reported to Health Canada (last updated June 15, 2026).
When will SODIUM PHOSPHATES INJECTION USP be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
00896187
Strength
268MG 276MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
SODIUM PHOSPHATE DIBASIC SODIUM PHOSPHATE MONOBASIC
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759